Vinod H. Thourani mainly focuses on Surgery, Internal medicine, Cardiology, Valve replacement and Aortic valve replacement. In Surgery, Vinod H. Thourani works on issues like Risk of mortality, which are connected to Aortic valvuloplasty. The Cardiology study combines topics in areas such as Anesthesia and Cardiothoracic surgery.
His Valve replacement study is concerned with the field of Stenosis as a whole. His study explores the link between Stenosis and topics such as Cohort that cross with problems in Randomization. Aortic valve replacement is closely attributed to High risk patients in his work.
The scientist’s investigation covers issues in Internal medicine, Cardiology, Surgery, Valve replacement and Aortic valve replacement. As part of his studies on Cardiology, Vinod H. Thourani often connects relevant areas like Stroke. His Stroke study integrates concerns from other disciplines, such as Anesthesia, Incidence, Myocardial infarction and Atrial fibrillation.
His Surgery study combines topics from a wide range of disciplines, such as Risk of mortality and Hazard ratio. His research in Hazard ratio intersects with topics in Survival rate and Proportional hazards model. The study incorporates disciplines such as Transcatheter aortic, Heart valve, Aortic valve stenosis and Cohort in addition to Valve replacement.
His primary areas of investigation include Internal medicine, Cardiology, Surgery, Valve replacement and Transcatheter aortic. His study looks at the relationship between Cardiology and fields such as Stroke, as well as how they intersect with chemical problems. His Surgery research is multidisciplinary, incorporating elements of Odds ratio and Heart failure.
The various areas that Vinod H. Thourani examines in his Valve replacement study include Risk of mortality, Retrospective cohort study and Cohort. In his study, Percutaneous is inextricably linked to Core laboratory, which falls within the broad field of Transcatheter aortic. His work in Aortic valve replacement tackles topics such as Aortic valve stenosis which are related to areas like Dialysis.
Vinod H. Thourani spends much of his time researching Internal medicine, Cardiology, Valve replacement, Surgery and Aortic valve replacement. His research integrates issues of Stroke, Anesthesia and Catheter in his study of Cardiology. His Valve replacement study integrates concerns from other disciplines, such as Transcatheter aortic, Risk of mortality, Retrospective cohort study and Hazard ratio.
Vinod H. Thourani interconnects Aortic valve stenosis and Randomized controlled trial in the investigation of issues within Aortic valve replacement. His Aortic valve stenosis research includes themes of Physical therapy, Quality of life and Cohort study. His Atrial fibrillation study incorporates themes from Mitral valve repair and Cardiothoracic surgery.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Transcatheter versus Surgical Aortic-Valve Replacement in High-Risk Patients
Craig R. Smith;Martin B. Leon;Michael J. Mack;D. Craig Miller.
The New England Journal of Medicine (2011)
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients.
Martin B Leon;Craig R. Smith;Michael J. Mack;Michael J. Mack;Rajendra Makkar.
The New England Journal of Medicine (2016)
Two-Year Outcomes after Transcatheter or Surgical Aortic-Valve Replacement
Susheel K. Kodali;Mathew R. Williams;Craig R. Smith;Lars G. Svensson.
The New England Journal of Medicine (2012)
5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial
Michael J Mack;Martin B Leon;Craig R Smith;D Craig Miller.
The Lancet (2015)
Transcatheter aortic valve replacement versus surgical valve replacement in intermediate-risk patients: a propensity score analysis
Vinod H. Thourani;Susheel Kodali;Raj R. Makkar;Howard C. Herrmann.
The Lancet (2016)
Transcatheter Versus Surgical Aortic-Valve Replacement in High-Risk Patients
Craig R. Smith;Martin B. Leon;Michael J. Mack;D. Craig Miller.
Survey of Anesthesiology (2012)
5-year outcomes of transcatheter aortic valve replacement compared with standard treatment for patients with inoperable aortic stenosis (PARTNER 1): a randomised controlled trial
Samir R Kapadia;Martin B Leon;Raj R Makkar;E Murat Tuzcu.
The Lancet (2015)
Two-Year Outcomes of Surgical Treatment of Moderate Ischemic Mitral Regurgitation.
Robert E. Michler;Peter K. Smith;Michael K. Parides;Gorav Ailawadi.
The New England Journal of Medicine (2016)
Influence of diabetes mellitus on early and late outcome after coronary artery bypass grafting.
Vinod H Thourani;William S Weintraub;Bernardo Stein;Suzanne S.P Gebhart.
The Annals of Thoracic Surgery (1999)
2016 Annual Report of The Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry
Frederick L. Grover;Sreekanth Vemulapalli;John D. Carroll;Fred H. Edwards.
Journal of the American College of Cardiology (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Emory University
Scott & White Memorial Hospital
Columbia University Medical Center
Mount Sinai Hospital
Cleveland Clinic
Columbia University Medical Center
Cleveland Clinic
University of Pennsylvania
Cedars-Sinai Medical Center
New York University
University of New South Wales
Duke University
Queen's University
Rice University
University of Colorado Boulder
University of Massachusetts Medical School
Charles University
Catholic University of the Sacred Heart
Stemcell Technologies
University of Western Brittany
University of Trás-os-Montes and Alto Douro
Drexel University
AstraZeneca (United Kingdom)
UCSF Benioff Children's Hospital
University of California, San Francisco
The Ohio State University